An Experience of Exenatide Therapeutic Drug Monitoring from Chang Gung Memorial Hospital
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: NIU, Suchen (Chang Gung Memorial Hospital, Department of Pharmacy, Taoyuan, China Taiwan)
- Co-author(s): Deng, S. (Chang Gung Memorial Hospital, Taoyuan, China Taiwan)
Background: GLP-1 receptor agonist exenatide in patients with type 2 diabetes has been proved to be effective in glycemic control.Aim: To compare the change in HbA1c, body weight and blood pressure for type 2 diabetic patients before and after treatment with exenatide twice daily in a usual-care setting.Methods: A retrospective study design of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.